Loading clinical trials...
Loading clinical trials...
Endoscopic Full-Thickness Plication for the Treatment of Gastroesophageal Reflux Disease: A Randomized, Sham-Controlled Trial
The aim of this study was to determine the effectiveness of endoscopic full-thickness plication (Plicator; NDO Surgical, Inc., Mansfield, MA) for the treatment of GERD in comparison to a sham procedure. Patients with symptomatic GERD requiring maintenance proton pump inhibitor therapy were entered into a randomized, single-blind, prospective, multicenter trial. Seventy-eight patients were randomly assigned to undergo endoscopic full-thickness restructuring of the gastric cardia with transmural suture. Eighty-one patients underwent a sham procedure. Group assignments were revealed following the 3-month evaluation. The primary endpoint was ≥ 50% improvement in GERD-HRQL score. Secondary endpoints included medication use and esophageal acid exposure. Patients achieving ≥ 50% improvement in GERD-HRQL score at 3-months versus baseline off-meds were considered responsive to their assigned procedure. Patients who failed to reach this level of improvement at 3-months were considered non-responders. Analysis of these dichotomized variables (responder/non-responder) was done using Fisher's exact test comparing the proportion of responders between the active and sham groups. Intent-to-treat analysis was also performed. The null hypothesis was that the proportion of responders was the same in both the active and sham groups. Testing was done at the 5% level of significance (alpha=0.05).
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
University of California at Irvine Medical Center
Orange, California, United States
Tri Valley Gastroenterology
San Ramon, California, United States
University of Colorado Health Science Center
Denver, Colorado, United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Creighton University Medical Center
Omaha, Nebraska, United States
Seacoast Gastroenterology
Exeter, New Hampshire, United States
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, United States
Lenox Hill Hospital
New York, New York, United States
Columbia University Medical Center
New York, New York, United States
Nashville Medical Research and the Maria Nathanson Center of Excellence
Nashville, Tennessee, United States
Start Date
January 1, 2005
Primary Completion Date
March 1, 2008
Completion Date
March 1, 2008
Last Updated
July 16, 2008
159
ACTUAL participants
NDO Full-thickness Plicator
DEVICE
Sham Control
DEVICE
Lead Sponsor
NDO Surgical, Inc.
NCT07344935
NCT07179250
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT01940185